Abstract | PURPOSE: EXPERIMENTAL DESIGN: In vitro cell models including stable expression and knockdown of DARPP-32 were used. The role of DARPP-32 in regulating TRAIL-dependent apoptosis was evaluated by clonogenic survival assay, Annexin V staining, immunofluorescence, quantitative reverse transcriptase PCR, Western blot, and luciferase reporter assays. RESULTS: Stable expression of DARPP-32 in MKN-28 cells enhanced cell survival and suppressed TRAIL-induced cytochrome c release and activation of caspase-8, -9, and -3. Conversely, short hairpin RNA-mediated knockdown of endogenous DARPP-32 sensitized the resistant MKN-45 cells to TRAIL-induced apoptosis and enhanced TRAIL-mediated activation of caspase-8, -9, and -3. DARPP-32 induced BCL-xL expression through activation of Src/STAT3 signaling, and treatment with the Src-specific inhibitor PP1 abrogated DARPP-32-dependent BCL-xL upregulation and cell survival in MKN-28 cells. The TRAIL treatment induced caspase-dependent cleavage of NF-κBp65 protein; this cleavage was prevented by DARPP-32, thus maintaining NF-κB activity and the expression of its target, FLIP(S) protein. This suggests that upregulation of BCL-xL could play a possible role in blocking the mitochondria intrinsic apoptosis pathway, whereas the DARPP-32 effect on the NF-κB/ FLIP(S) axis could serve as an additional negative feedback loop that blocks TRAIL-induced activation of caspase-8. CONCLUSION: Our findings uncover a novel mechanism of TRAIL resistance mediated by DARPP-32, whereby it inhibits the intrinsic apoptosis pathway through upregulation of BCL-xL, and the extrinsic apoptosis pathway through the NF-κB/ FLIP(S) axis.
|
Authors | Abbes Belkhiri, Shoumin Zhu, Zheng Chen, Mohammed Soutto, Wael El-Rifai |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 18
Issue 14
Pg. 3889-900
(Jul 15 2012)
ISSN: 1557-3265 [Electronic] United States |
PMID | 22589394
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- BCL2L1 protein, human
- CASP8 and FADD-Like Apoptosis Regulating Protein
- Dopamine and cAMP-Regulated Phosphoprotein 32
- NF-kappa B
- PPP1R1B protein, human
- TNF-Related Apoptosis-Inducing Ligand
- TNFSF10 protein, human
- bcl-X Protein
- Caspases
|
Topics |
- Apoptosis
(drug effects, genetics)
- CASP8 and FADD-Like Apoptosis Regulating Protein
(metabolism)
- Caspases
(metabolism)
- Cell Line, Tumor
- Cell Transformation, Neoplastic
(drug effects, genetics)
- Dopamine and cAMP-Regulated Phosphoprotein 32
(genetics, metabolism)
- Gene Expression Regulation, Neoplastic
(drug effects, genetics)
- Humans
- NF-kappa B
(metabolism)
- Signal Transduction
- Stomach Neoplasms
(genetics, metabolism)
- TNF-Related Apoptosis-Inducing Ligand
(administration & dosage, genetics)
- bcl-X Protein
(metabolism)
|